managing glp 1 side effects How To Manage GLP-1 Peptide/GLP-1 Complications: 11 Hidden Risks
Description
Recent studies...
Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide
McDonalds is the latest fast-food chain to jump on the GLP-1 train, testing new menu items to appeal to growing swaths of customers on the popular weight-loss drugs.
PlexusDx explains the safety profile, potential interactions, and how personalized peptide therapy can support your health goals
Orforglipron, Lillys first small-molecule oral GLP-1 receptor agonist in Phase 3, showed meaningful weight loss and glycemic control in adults with type 2 diabetes and overweight or obesity
Learn how to support GLP-1 weight-loss coverage using wellness stipends and LSAs
